You have 9 free searches left this month | to do more

cytarabine

Cytarabine is a drug used to treat Leukemia, Acute Myeloid Leukemia, Lymphoma, and other conditions. Cytarabine is being actively studied in 204 studies and prior, has been studied in 391.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Roswell Park Cancer InstituteAmir Fathi
M.D. Anderson Cancer CenterWashington University School of MedicineProf. Dr. Hartmut Doehner
Children's Oncology GroupChildren's National Medical CenterJulie M Vose, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Acute Myeloid Leukemia
  • Cytarabine
  • Gainesville, Florida
    University of Florida
2022-03-15
Mar 15, 2022
H
Active, not recruiting
  • Leukemia
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
M
Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Liposomal Annamycin
  • Cytarabine
  • Poznań, Poland
    Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
2022-04-05
Apr 5, 2022
J
Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Miami, Florida
    University of Miami
2021-12-07
Dec 7, 2021
W
Active, not recruiting
  • Mantle Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-02-02
Feb 2, 2022
U
Terminated
  • Acute Myeloid Leukemia
  • Cytarabine
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
2021-07-01
Jul 1, 2021
W
Active, not recruiting
  • Mantle Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-05-21
May 21, 2021
P
Recruiting
  • Acute Leukemia
  • Tampa, Florida
  • +1 more
2021-02-08
Feb 8, 2021
P
Recruiting
  • Langerhans Cell Histiocytosis
  • Cytarabine
  • Beijing, China
    Peking Union Medical College Hospital
2021-06-07
Jun 7, 2021
M
Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Cytarabine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-01
Mar 1, 2022
B
Recruiting
  • Langerhans Cell Histiocytosis
  • San Diego, California
  • +4 more
2021-06-02
Jun 2, 2021
M
Recruiting
  • Acute Myeloid Leukemia
  • Cytarabine
  • +5 more
  • Duarte, California
  • +2 more
2022-01-21
Jan 21, 2022
M
Recruiting
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-25
Jun 25, 2021
F
Recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-15
Mar 15, 2022
S
Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Cladribine Injection
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2020-12-15
Dec 15, 2020
V
Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • New Haven, Connecticut
  • +2 more
2021-09-08
Sep 8, 2021
N
Completed
  • Acute Myeloid Leukemia (AML)
  • cytarabine
  • +2 more
  • Los Angeles, California
  • +5 more
2020-12-16
Dec 16, 2020
M
Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-18
Mar 18, 2022
G
Completed
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Frankfurt am Main, Hessen, Germany
  • +2 more
2021-08-01
Aug 1, 2021
R
Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2020-09-22
Sep 22, 2020